CDSCO declares 330 drug samples not of standard quality in September 2026 list
CDSCO's September 2026 alert lists 330 drug samples declared not of standard quality, including injections that failed sterility tests, according to the regulator's laboratories.
Key points
- CDSCO has listed 330 drug samples declared not of standard quality in its monthly alert for September 2026.
- According to the list, 42 samples were tested by CDSCO laboratories and 288 by State drug testing laboratories.
- Readers can check the batch number on their medicine pack against CDSCO's list on its NSQ alerts portal.
The Central Drugs Standard Control Organisation (CDSCO) has listed 330 drug samples declared not of standard quality in its monthly alert for September 2026. According to the list, 42 samples were tested by CDSCO laboratories and 288 by State drug testing laboratories. Each entry names the product, batch number, manufacturer, the test it failed and the laboratory that tested it.
What Happened
Per CDSCO's list, the CDSCO laboratory CDL, Kolkata found that Compound Sodium Lactate Injection I.P. (RL 500 ml), batch EE26A009, made by Hindustan Polyfab, Baddi, failed the test for sterility. The same laboratory found that Iron Sucrose Injection USP batches MFS-117, MFS-129, MFS-133, MFS-134 and MFS-136, made by Marc Laboratories Ltd., Baddi, failed the tests for pH and alkalinity, and that Thyroxine Tablets IP 25 mcg, batch T-639, made by Jackson Laboratories Pvt. Ltd., Amritsar, failed the assay of thyroxine sodium.
The CDSCO laboratory RDTL, Guwahati found that Oxytocin Injection IP, batch IA26-64, made by Om Biomedic Pvt. Ltd., Haridwar, did not comply with the tests for bacterial endotoxins and sterility, the list says.
Among State laboratory results, SDTL, Punjab found that Calcium Carbonate with Vitamin D3 Tablets IP, batch PB2607001, made by Kanha Biogenetic, Baddi, contained 80.20% of the stated calcium and 1.798% of the stated vitamin D3. The state laboratory at Chhatrapati Sambhajinagar, Maharashtra, found tadalafil in Urja Urbpro Capsule, batch URJA702, labelled as made by Urbofort, and declared the sample spurious under Section 33-EEA(d) of the Drugs and Cosmetics Act, 1940.
According to the list, the manufacturers with the most samples were Unicure India Ltd. (16) and Yacca Pharmaceuticals Pvt. Ltd. (8). SDTL, Punjab found that six batches of Yacca's Salbutamol Sulphate Syrup IP, AS-6364, AS-6365, AS-6366, AS-6368, AS-6370 and AS-6371, failed the pH test.
What It Means
The list identifies each failed sample by its batch number. Readers can check the batch number printed on their medicine pack against CDSCO's full list for September 2026 on its NSQ alerts portal at cdscoonline.gov.in. The list covers common medicines such as antibiotics, painkillers, cough syrups and intravenous fluids, so it is worth checking packs bought recently.
This report describes enforcement actions and allegations on the public record, attributed to the officials cited. An order, FIR or chargesheet is not a conviction; parties are presumed innocent until proven guilty.
Named in this report, or spotted an error? Corrections and responses: editor@oquilia.com. We correct errors promptly and record responses from named parties.
Sources & Citations
- CDSCO list of drugs not of standard quality — Central Drugs Standard Control Organisation